All Stories

  1. Fluid Biomarkers of Motor and Non-Motor Experiences of Daily Living in Dementia with Lewy Bodies and Alzheimer’s Disease
  2. Neuroprotective and anti-inflammatory effects of cannabidiol in rats submitted to severe traumatic brain injury
  3. Anthropometric and Demographic Features Affect the Interpretation of Cerebrospinal Fluid Biomarkers in Patients with Different Dementia Syndromes and Cognitively Healthy Adults
  4. Posttraumatic epilepsy: Integrating clinical, inflammatory, and genetic profiles in traumatic brain injury patients
  5. Initial clinical evidence on biperiden as antiepileptogenic after traumatic brain injury—a randomized clinical trial
  6. What we have learned from non-human primates as animal models of epilepsy
  7. miR-9-5p is Downregulated in Serum Extracellular Vesicles of Patients Treated with Biperiden After Traumatic Brain Injury
  8. Biofluid Activity and Levels of the Angiotensin-converting Enzyme Are Surrogates for Diverse Cerebrospinal Fluid Amyloid-beta Effects in Dementia with Lewy Bodies and Alzheimer’s Dementia (P6-9.001)
  9. miR-9-5p is downregulated in serum extracellular vesicles of patients treated with biperiden after traumatic brain injury
  10. Differential performance of cerebrospinal fluid biomarker ratios and formulas to discriminate dementia with Lewy bodies from Alzheimer’s dementia and cognitively healthy people reflects high level of amyloidosis across dementia syndromes
  11. Biofluid activity and levels of the angiotensin‐converting enzyme may translate into distinct neuropsychiatric symptoms associated with cerebrospinal fluid amyloid‐beta effects and tauopathy in dementia with Lewy bodies and Alzheimer’s dementia
  12. Disparities in neuropsychiatric symptom clusters across dementia diagnoses within Lewy body dementia syndromes and Alzheimer’s dementia
  13. Initial clinical evidence on biperiden as antiepileptogenic after traumatic brain injury. A Randomized Clinical Trial
  14. T76. DOWNREGULATION OF MIR-9-5P IN PATIENTS TREATED WITH BIPERIDEN AFTER TRAUMATIC BRAIN INJURY
  15. Differential associations of clinical features with cerebrospinal fluid biomarkers in dementia with Lewy bodies and Alzheimer’s disease
  16. Lifestyle and pharmacological interventions in South America: Potential barriers for recruitment, implementation, and effectiveness
  17. Anticholinergics: A potential option for preventing posttraumatic epilepsy
  18. Immunofluorescence co-localization of progesterone receptor with glutamatergic interneurons in the ca3 hippocampal region of an ovariectomized female proechimys guyannensis
  19. Associations of Neuropsychiatric Features with Cerebrospinal Fluid Biomarkers of Amyloidogenesis and Neurodegeneration in Dementia with Lewy Bodies Compared with Alzheimer’s Disease and Cognitively Healthy People
  20. APOE-ɛ4-mediated correlates of cerebrospinal fluid biomarkers of amyloidosis and neurodegeneration with cognition and functionality in dementia with Lewy bodies compared with Alzheimer’s dementia and cognitively healthy people (49)
  21. Hormonal and biochemical changes in female Proechimys guyannensis, an animal model of resistance to pilocarpine-induced status epilepticus
  22. Neuropsychiatric feature profiles of patients with Lewy body dementia
  23. Sleep deprivation changes thimet oligopeptidase (THOP1) expression and activity in rat brain
  24. What role sex hormones play in the hippocampus of Amazon rodent submitted to lithium-pilocarpine?
  25. Plasma kallikrein‐kinin system contributes to peripheral inflammation in temporal lobe epilepsy
  26. CEREBROSPINAL-FLUID-BASED BIOMARKER EVIDENCE OF AMYLOIDOGENESIS IN DEMENTIA WITH LEWY BODIES DEPENDS UPON APOE-ε4 CARRIER STATUS
  27. BEHAVIORAL CORRELATES OF CEREBROSPINAL FLUID BIOMARKERS ACCORDING TO APOE-ε4 CARRIER STATUS IN DEMENTIA WITH LEWY BODIES COMPARED WITH ALZHEIMER’S DEMENTIA AND COGNITIVELY HEALTHY PEOPLE
  28. Renal denervation reduces sympathetic overactivation, brain oxidative stress, and renal injury in rats with renovascular hypertension independent of its effects on reducing blood pressure
  29. Botulinum toxin A (BT-A) versus low-level laser therapy (LLLT) in chronic migraine treatment: a comparison
  30. Lifetime Risk Factors for Functional and Cognitive Outcomes in Patients with Alzheimer’s Disease
  31. Protective Role of UCP2 in Oxidative Stress and Apoptosis during the Silent Phase of an Experimental Model of Epilepsy Induced by Pilocarpine
  32. GENETICALLY MEDIATED LIFETIME RISK FACTORS FOR COGNITIVE AND FUNCTIONAL DECLINE IN PATIENTS WITH ALZHEIMER’S DEMENTIA FROM SÃO PAULO, BRAZIL
  33. COGNITIVE AND FUNCTIONAL CORRELATES OF CEREBROSPINAL FLUID CONCENTRATIONS OF AMINOACIDS AND MONOAMINE METABOLITES ACCORDING TO APOE-ε4 CARRIER STATUS IN DEMENTIA WITH LEWY BODIES COMPARED WITH ALZHEIMER’S DEMENTIA AND COGNITIVELY HEALTHY PEOPLE
  34. Behavioral correlates of cerebrospinal fluid concentrations of aminoacids and monoamine metabolites according to APOE-ɛ4 carrier status in dementia with Lewy bodies compared with Alzheimer’s dementia and cognitively healthy people (P4.190)
  35. Protective Role of UCP2 against Oxidative Stress through Survival Signaling Pathway in Acute Epilepsy induced by Pilocarpine in Rats
  36. Neurochemical Changes and c-Fos Mapping in the Brain after Carisbamate Treatment of Rats Subjected to Lithium–Pilocarpine-Induced Status Epilepticus
  37. MOTOR ASPECTS OF DAILY LIVING FOLLOW COGNITIVE AND FUNCTIONAL STATUS BUT NOT BEHAVIOURAL SYMPTOMS IN PATIENTS WITH LEWY BODY DEMENTIA SYNDROMES
  38. Maternal seizures can affect the brain developing of offspring
  39. Methadone Increases and Prolongs Detomidine-Induced Arterial Hypertension in Horses, but These Effects Are Not Mediated by Increased Plasma Concentrations of Arginine Vasopressin or Serum Concentrations of Catecholamines
  40. High serum levels of proinflammatory markers during epileptogenesis. Can omega-3 fatty acid administration reduce this process?
  41. Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson’s Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties
  42. P.1.g.020 Valproic acid exerts a neuroprotective action in the 6-OHDA-induced Parkinson’s disease model
  43. Indomethacin can downregulate the levels of inflammatory mediators in the hippocampus of rats submitted to pilocarpine-induced status epilepticus
  44. Lovastatin decreases the synthesis of inflammatory mediators during epileptogenesis in the hippocampus of rats submitted to pilocarpine-induced epilepsy
  45. What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders?
  46. Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions
  47. Expression and activity of thimet oligopeptidase (TOP) are modified in the hippocampus of subjects with temporal lobe epilepsy (TLE)
  48. Sleep loss changes neuropeptidase expression and activty in rat brain (876.3)
  49. Lovastatin and sudden unexpected death in epilepsy: A matter for debate
  50. Exercise-induced hippocampal anti-inflammatory response in aged rats
  51. Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties
  52. Piperine decreases pilocarpine-induced convulsions by GABAergic mechanisms
  53. The levels of renin–angiotensin related components are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy
  54. Interleukin-6 bares a dark side in sudden unexpected death in epilepsy
  55. Consequences of pilocarpine-induced status epilepticus in immunodeficient mice
  56. Carbamazepine inhibits angiotensin I-converting enzyme, linking it to the pathogenesis of temporal lobe epilepsy
  57. Masruha et al. reply
  58. Stress during development alters anxiety-like behavior and hippocampal neurotransmission in male and female rats
  59. Neuroglobin is up‐regulated in the cerebellum of pups exposed to maternal epileptic seizures
  60. Melatonin administration after pilocarpine-induced status epilepticus: A new way to prevent or attenuate postlesion epilepsy?
  61. Kallikrein 1 is overexpressed by astrocytes in the hippocampus of patients with refractory temporal lobe epilepsy, associated with hippocampal sclerosis
  62. Neuroprotective effect of pyruvate and oxaloacetate during pilocarpine induced status epilepticus in rats
  63. Relationship between fluid-attenuated inversion-recovery (FLAIR) signal intensity and inflammatory mediator's levels in the hippocampus of patients with temporal lobe epilepsy and mesial temporal sclerosis
  64. Lovastatin decreases the synthesis of inflammatory mediators in the hippocampus and blocks the hyperthermia of rats submitted to long-lasting status epilepticus
  65. Malnutrition in Infancy as a Susceptibility Factor for Temporal Lobe Epilepsy in Adulthood Induced by the Pilocarpine Experimental Model
  66. Spontaneous periodic hypothermia and hyperhidrosis: a possibly novel cerebral neurotransmitter disorder
  67. Early exercise promotes positive hippocampal plasticity and improves spatial memory in the adult life of rats
  68. Physical exercise in adolescence changes CB1 cannabinoid receptor expression in the rat brain
  69. Seizures during pregnancy modify the development of hippocampal interneurons of the offspring
  70. Hippocampal expression and distribution of CB1 receptors in the Amazonian rodent Proechimys: An animal model of resistance to epilepsy
  71. Behavioral evaluation of adult rats exposed in utero to maternal epileptic seizures
  72. 94. Melatonin levels are decreased in rats with epilepsy induced by pilocarpine
  73. Akt pathway activation and increased neuropeptide Y mRNA expression in the rat hippocampus: Implications for seizure blockade
  74. Pathophysiological Aspects of Temporal Lobe Epilepsy and the Role of P2X Receptors
  75. Rasmussen Encephalitis: longterm outcome after surgery
  76. The pilocarpine model of epilepsy: what have we learned?
  77. Nestin down-regulation of cortical radial glia is delayed in rats submitted to recurrent status epilepticus during early postnatal life
  78. Melatonin treatment decreases c-fos expression in a headache model induced by capsaicin
  79. Rasmussen encephalitis: long-term outcome after surgery
  80. Neurogenesis induced by seizures in the dentate gyrus is not related to mossy fiber sprouting but is age dependent in developing rats
  81. Serotonin depletion effects on the pilocarpine model of epilepsy
  82. Effect of hormonal replacement therapy in the hippocampus of ovariectomized epileptic female rats using the pilocarpine experimental model
  83. The renin‐angiotensin system is upregulated in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis
  84. Chondroitin sulfate and kallikrein in saliva: Markers for glossodynia
  85. Idiopathic Intracranial Hypertension With and Without Papilloedema in a Consecutive Series of Patients With Chronic Migraine
  86. Bone marrow cells are able to increase vessels number during repair of sciatic nerve lesion
  87. Kinin B1 receptors facilitate the development of temporal lobe epilepsy in mice
  88. Cardiovascular protective effect of melatonin in sudden unexpected death in epilepsy: A hypothesis
  89. Glutamate Levels in Cerebrospinal Fluid and Triptans Overuse in Chronic Migraine
  90. Effects of different types of physical exercise on the staining of parvalbumin-positive neurons in the hippocampal formation of rats with epilepsy
  91. Estudo comparativo entre enxerto autógeno e enxerto muscular coberto com tubo de veia autógeno em nervos tibiais de ratos wistar, utilizando o fluoro-gold® como marcador neuronal
  92. Kinin B1 and B2 receptors are overexpressed in the hippocampus of humans with temporal lobe epilepsy
  93. Effect of aerobic physical exercise in pinealectomized animals submitted to the pilocarpine model of epilepsy
  94. Effect of glycemic state in rats submitted to status epilepticus during development
  95. Efeito neuroprotetor da melatonina e N-acetilserotonina na epileptogênese e no controle de crises em animais submetidos ao modelo da pilocarpina
  96. Cerebrospinal fluid GABA levels in chronic migraine with and without depression
  97. Investigation of mitochondrial involvement in the experimental model of epilepsy induced by pilocarpine
  98. Effects of pinealectomy and the treatment with melatonin on the temporal lobe epilepsy in rats
  99. Expression of nestin in the hippocampal formation of rats submitted to the pilocarpine model of epilepsy
  100. Status epilepticus induced by pilocarpine and Ca2+ transport by microsome in the hippocampus of rats
  101. Expression of apoptosis inhibitor protein Mcl1 linked to neuroprotection in CNS neurons
  102. Role of kinin B1 and B2 receptors in the development of pilocarpine model of epilepsy
  103. The synthesis and distribution of the kinin B1 and B2 receptors are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy
  104. Pilocarpine-induced status epilepticus increases glutamate release in rat hippocampal synaptosomes
  105. Levels of the synaptic protein X11 alpha/mint1 are increased in hippocampus of rats with epilepsy
  106. Mesangial cells are able to produce catecholamines in vitro
  107. Glycosaminoglycan levels and proteoglycan expression are altered in the hippocampus of patients with mesial temporal lobe epilepsy
  108. Extracellular Matrix Components are Altered in the Hippocampus, Cortex, and Cerebrospinal Fluid of Patients with Mesial Temporal Lobe Epilepsy
  109. Evidence That ATP Participates in the Pathophysiology of Pilocarpine-Induced Temporal Lobe Epilepsy: A Fluorimetric, Immunohistochemical, and Western Blot Studies
  110. Amino acid and monoamine alterations in the cerebral cortex and hippocampus of mice submitted to ricinine-induced seizures
  111. Castration in female rats modifies the development of the pilocarpine model of epilepsy
  112. Superoxide dismutase, glutathione peroxidase activities and the hydroperoxide concentration are modified in the hippocampus of epileptic rats
  113. Catecholamine response to exercise in individuals with different levels of paraplegia
  114. Selective alterations of glycosaminoglycans synthesis and proteoglycan expression in rat cortex and hippocampus in pilocarpine-induced epilepsy
  115. Growth-associated phosphoprotein expression is increased in the supragranular regions of the dentate gyrus following pilocarpine-induced seizures in rats
  116. Mitogen-activated protein kinase is increased in the limbic structures of the rat brain during the early stages of status epilepticus
  117. Tyrosine phosphorylation is increased in the rat hippocampus during the status epilepticus induced by pilocarpine
  118. Monoamine responses to acute and chronic aerobic exercise in normotensive and hypertensive subjects
  119. Monoamines and their metabolites in cerebrospinal fluid and temporal cortex of epileptic patients
  120. Na+K+ ATPase activity in the rat hippocampus: A study in the pilocarpine model of epilepsy
  121. Profile of prostaglandin levels in the rat hippocampus in pilocarpine model of epilepsy
  122. Spontaneous Recurrent Seizures in Rats: Amino Acid and Monoamine Determination in the Hippocampus
  123. Rat liver kininase, a serine peptidase
  124. Inactivation of kinins by chymotrypsin